Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

Por Xu, Zhenshu, Cang, Shundong, Yang, Ting, Liu, Delong
Publicado em 2009

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting

Por Zhao, Jiangning, Xu, Zhenshu, Liu, Delong, Lu, Quanyi
Publicado em 2012

Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

Por XU, ZHENSHU, ZHANG, JINYAN, WU, SHUNQUAN, ZHENG, ZHIHONG, CHEN, ZHIZHE, ZHAN, RONG
Publicado em 2013

Bone marrow stromal cells enhance the survival of chronic lymphocytic leukemia cells by regulating HES-1 gene expression and H3K27me3 demethylation

Por Xu, Zhenshu, Xiong, Donglian, Zhang, Jushun, Zhang, Jingyan, Chen, Xiuli, Chen, Zhizhe, Zhan, Rong
Publicado no Oncol Lett (2018)